ArticleJournal of natural medicines2026

Casticin inhibits AKR1C3 and enhances abiraterone efficacy in castration-resistant prostate cancer.

Kamil Piska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.